July 18th 2024
The FDA has issued a complete response letter to Orexo for OX124, a high-dose naloxone nasal spray for opioid overdose reversal.
Reducing Opioid-Involved Overdose Deaths: States’ Prevention and Response Efforts
August 19th 2021In this journal club, a medical student and an addiction psychiatrist review a thematic analysis of successful prevention efforts in states with declining rates of opioid-related overdose deaths.
Read More
Setting the Stage for Opioid Addiction Treatment
June 8th 2015Opioid-dependent patients presenting to an emergency department for other medical reasons are more likely to pursue addiction treatment if a specific therapy is initiated during their emergency care stay. What therapy are we talking about?
Read More